Related Experiment Video
Updated: Jul 14, 2026
04:44
Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex
Published on: February 16, 2024
Paliperidone extended-release tablets: a new atypical antipsychotic
1University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pennsylvania 15213, USA. HowlandRH@upmc.edu
Summary
Paliperidone extended-release (Pal-ER) offers continuous drug delivery, minimizing side effects associated with immediate-release antipsychotics. This new formulation is effective, safe, and a potential alternative for select patients.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Psychiatry
Background:
- Atypical antipsychotics are crucial in managing psychiatric disorders.
- Immediate-release formulations can lead to fluctuating serum drug concentrations and side effects.
- The development of novel drug delivery systems aims to improve patient outcomes.
Purpose of the Study:
- To review the clinical use of paliperidone extended-release (Pal-ER).
- To evaluate the efficacy, safety, and tolerability of Pal-ER.
- To compare Pal-ER with other antipsychotic medications.
Main Methods:
- Review of existing literature on paliperidone extended-release.
- Analysis of pharmacokinetic data regarding drug delivery and serum concentrations.
- Assessment of clinical trial data on efficacy and safety profiles.
Main Results:
- Pal-ER provides continuous drug delivery over 24 hours, reducing serum concentration fluctuations.
- This delayed-release mechanism minimizes side effects linked to high peak levels.
- Pal-ER demonstrates effectiveness, safety, and good tolerability in clinical use.
Conclusions:
- Paliperidone extended-release is an effective and safe atypical antipsychotic.
- Its unique delayed-release formulation offers potential benefits by reducing side effects.
- Pal-ER may serve as a valuable alternative medication for specific patient populations.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...